Concepedia

Vaishali Humnabadkar

VH

Statistics

Publications

16

Citations

934

H-Index

15

Active since

2011

Affiliations

AstraZeneca (India)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

École Polytechnique Fédérale de Lausanne

AstraZeneca (South Korea)

Vaishali Humnabadkar is an author at AstraZeneca (India) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

2011–2016

16

Publications

16

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious <i>in Vivo</i>

Pravin S. Shirude, Radha Krishan Shandil, C Sadler et al. · Journal of Medicinal Chemistry · 2013 · 162 citations

, , +14

4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity

Maruti Naik, Vaishali Humnabadkar, Subramanyam J. Tantry et al. · Journal of Medicinal Chemistry · 2014 · 94 citations · Full text

, , +16

Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity

Manoranjan Panda, Sreekanth A. Ramachandran, Vasanthi Ramachandran et al. · Journal of Medicinal Chemistry · 2014 · 94 citations

, , +17

Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents

Pravin S. Shirude, Radha Krishan Shandil, M. R. Manjunatha et al. · Journal of Medicinal Chemistry · 2014 · 89 citations · Full text

, , +17

Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>

Pravin S. Shirude, Prashanti Madhavapeddi, Julie A. Tucker et al. · ACS Chemical Biology · 2012 · 88 citations

, , +17

1–5 of 16